BeiGene Ltd. (49B) — Financial Flexibility Index

Latest as of March 2025: 0.07x

BeiGene Ltd. (49B) has a Financial Flexibility Index of 0.07x as of March 2025. Free cash flow of €160.49 Million (operating CF €44.08 Million minus capex €116.41 Million) represents 0% of total liabilities (€2.34 Billion). Also explore 49B shareholders equity momentum to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

0.07x
Free Cash Flow / Total Liabilities

Free Cash Flow

€160.49 Million
Operating CF − Capex

Total Liabilities

€2.34 Billion
EUR

Capital Expenditures

€116.41 Million
EUR

BeiGene Ltd. Financial Flexibility Index (2016–2024)

Historical Financial Flexibility Index trend for BeiGene Ltd. across 9 annual periods. Check asset allocation strategy of BeiGene Ltd. to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for BeiGene Ltd. (2016–2024)

Year-by-year free cash flow to debt coverage for BeiGene Ltd.. For the full company profile including market capitalisation, see 49B company net worth.

Year Flexibility Index Free Cash Flow (EUR) Operating CF Total Liabilities YoY Change
2024 0.15x €388.51 Million €-140.63 Million €2.59 Billion ▲ +152.0%
2023 -0.29x €-654.63 Million €-1.25 Billion €2.27 Billion ▲ +50.8%
2022 -0.59x €-1.17 Billion €-1.50 Billion €2.00 Billion ▼ -36.1%
2021 -0.43x €-1.04 Billion €-1.30 Billion €2.40 Billion ▲ +36.0%
2020 -0.67x €-1.17 Billion €-1.28 Billion €1.73 Billion ▲ +35.4%
2019 -1.04x €-660.66 Million €-750.27 Million €633.93 Million ▼ -8.3%
2018 -0.96x €-477.43 Million €-547.72 Million €496.04 Million ▼ -689.7%
2017 0.16x €59.13 Million €12.75 Million €362.25 Million ▲ +113.1%
2016 -1.25x €-66.01 Million €-89.51 Million €52.91 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities